Evidence map›Paper›PMID 36404709›Full record

ReviewArtificial organs2023

Loss of pulsatility with continuous-flow left ventricular assist devices and the significance of the arterial endothelium in von-Willebrand factor production and degradation.

Guruprasad A Giridharan, Ian C Berg, Esraa Ismail, Khanh T Nguyen, Jana Hecking, James K Kirklin, Xuanhong Cheng, Palaniappan Sethu

Open access · greenAbstract readReview
In one paragraph

Review in Artificial organs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Guruprasad A GiridharanDepartment of Bioengineering, J. B. Speed School of Engineering, University of Louisville, Louisville, Kentucky, USA.ORCID https://orcid.org/0000-0003-3263-9354
Ian C BergDivision of Cardiovascular Disease, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0003-2302-7006
Esraa IsmailDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-8020-6997
Khanh T NguyenDivision of Cardiovascular Disease, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0003-1233-7527
Jana HeckingDivision of Cardiovascular Disease, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0003-1919-7766
James K KirklinDivision of Cardiothoracic Surgery, Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0002-7861-3267
Xuanhong ChengDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-6331-8572
Palaniappan SethuDivision of Cardiovascular Disease, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0002-5794-2037
University of Alabama at Birmingham · USLehigh University · USUniversity of Louisville · US

Funding

MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASEST32HL007457 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Martin E Young · 1985 to 2026
$8.6M
Selection of Flow Modulation Protocols for Patients on Continuous Flow Ventricular Assist Devices (CF-VADs)R01HL151663 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SETHU, PALANIAPPAN · 2021 to 2024
$2.3M
Basic and Translational Science in Heart FailureT32HL129948 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YOUNG, MARTIN E · 2017 to 2021
$1.4M
NHLBI NIH HHS R01 HL151663NHLBI NIH HHS T32 HL007457NHLBI NIH HHS T32 HL129948
6 · The paper itself

Abstract

backgroundPatients on continuous flow ventricular assist devices (CF-VADs) are at high risk for the development of Acquired von-Willebrand Syndrome (AVWS) and non-surgical bleeding. von Willebrand Factor (vWF) plays an essential role in maintaining hemostasis via platelet binding to the damaged endothelium to facilitate coagulation. In CF-VAD patients, degradation of vWF into low MW multimers that are inefficient in facilitating coagulation occurs and has been primarily attributed to the supraphysiological shear stress associated with the CF-VAD impeller.

methodsIn this review, we evaluate information from the literature regarding the unraveling behavior of surface-immobilized vWF under pulsatile and continuous flow pertaining to: (A) the process of arterial endothelial vWF production and release into circulation, (B) the critical shear stress required to unravel surface bound versus soluble vWF which leads to degradation, and (C) the role of pulsatility in on the production and degradation of vWF. RESULTS AND

conclusionTaken together, these data suggests that the loss of pulsatility and its impact on arterial endothelial cells plays an important role in the production, release, unraveling, and proteolytic degradation of vWF into low MW multimers, contributing to the development of AVWS. Restoration of pulsatility can potentially mitigate this issue by preventing AVWS and minimizing the risk of non-surgical bleeding.

Indexed as

Heart-Assist Devicesvon Willebrand DiseasesEndothelial CellsEndotheliumHemorrhageHumansvon Willebrand Factorvon Willebrand Factoracquired von Willebrand syndromecontinuous flowloss of pulsatilityvon Willebrand Factor

Identifiers

PMID36404709
PMCPMC10065921
OpenAlexW4309517587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.